Literature DB >> 10486921

Pathogenic and vaccine significance of toxin-coregulated pili of Vibrio cholerae E1 Tor.

S R Attridge1, E Voss, P A Manning.   

Abstract

Vibrio cholerae O1 strains are classified into one of two biotypes, classical and E1 Tor, the latter being primarily responsible for cholera cases worldwide since 1961. Recent studies in our laboratory have focused upon the pathogenic and vaccine significance of the toxin-coregulated pili (TCP) produced by strains of E1 Tor biotype. Mutants in which the tcpA gene (encoding the pilin subunit protein) has been inactivated are dramatically attenuated in the infant mouse cholera model, showing markedly reduced colonisation potential in mixed-infection competition experiments. Significantly, in the vaccine context, antibodies to TCP are sufficient to prevent experimental infection, although our data suggest that this protective effect might be limited to strains of homologous biotype. Since we have shown that tcpA sequences are conserved within a biotype but differ between biotypes, this latter observation suggests that the biotype-restricted pilin epitopes might have greater vaccine significance. Similar studies indicate that TCP also play a critical role in colonisation by strains of the recently-recognised O139 serogroup, which is thought to have evolved from an O1 E1 Tor strain. In contrast to the effect of introducing mutations in the tcpA gene, strains carrying inactivated mshA genes (encoding the subunit of the mannose-sensitive haemagglutinin pilus) show unaltered in vivo behaviour. Consistent with this finding is our inability to demonstrate any protective effect associated with antibodies to MSHA. Ongoing approaches to vaccine development are variously aimed at improving the immunogenicity of the current inactivated whole-cell vaccine, or assessing the field efficacy of a promising live attenuated strain. The possible implications of our findings are discussed in relation to both of these options.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10486921     DOI: 10.1016/s0168-1656(99)00114-5

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  4 in total

1.  Evaluation of a broadly protective Chlamydia-cholera combination vaccine candidate.

Authors:  F O Eko; D N Okenu; U P Singh; Q He; C Black; J U Igietseme
Journal:  Vaccine       Date:  2011-03-21       Impact factor: 3.641

2.  Evaluation of multicomponent recombinant vaccines against Actinobacillus pleuropneumoniae in mice.

Authors:  Meili Shao; Yong Wang; Chunlai Wang; Yang Guo; Yonggang Peng; Jiandong Liu; Guangxing Li; Huifang Liu; Siguo Liu
Journal:  Acta Vet Scand       Date:  2010-09-11       Impact factor: 1.695

3.  The broad host range pathogen Pseudomonas aeruginosa strain PA14 carries two pathogenicity islands harboring plant and animal virulence genes.

Authors:  Jianxin He; Regina L Baldini; Eric Déziel; Maude Saucier; Qunhao Zhang; Nicole T Liberati; Daniel Lee; Jonathan Urbach; Howard M Goodman; Laurence G Rahme
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

4.  Production of putative enhanced oral cholera vaccine strains that express toxin-coregulated pilus.

Authors:  Caitlyn A Hauke; Ronald K Taylor
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.